JoyceDFingerothMD
Infectious Disease • Worcester, MAAssociate Professor of Medicine, Beth Israel Deaconess Medical Center
Dr. Fingeroth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
119 Belmont St
Worcester, MA 01605Phone+1 508-334-5214
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 1977 - 1980
New York University School of MedicineClass of 1977
Certifications & Licensure
MA State Medical License 1980 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 4 citationsThe association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study.Yujing Jan Heng, Susan Love, Jessica Clague DeHart, Joyce D Fingeroth, Gerburg M Wulf
Breast Cancer. 2022-07-01 - 4 citationsSerotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein-Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lym...Elham Ahmadi, Mehrdad Ravanshad, Jun Xie, Rajesh Panigrahi, Sandeep Jubbal
Virology Journal. 2021-11-18 - 12 citationsComplete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and DexamethasoneJames P Dugan, Bradley M. Haverkos, Linda Villagomez, Ludmila Katherine Martin, Mark E. Lustberg
Clinical Cancer Research. 2018-07-15
Press Mentions
New Clues to Epstein-Barr VirusFebruary 21st, 2013
Grant Support
- Formins (FHOS) In Cd21-Mediated Signaling &Virus EntryNational Institute Of Allergy And Infectious Diseases2005–2009
- The Structural Basis Of EBV Attachment: CD21 &Gp350/220National Institute Of Dental &Craniofacial Research2004–2005
- Treatment Of Virus Associated Proliferative DisordersNational Cancer Institute1999–2003
- Design Of Ebvtk Substrates To Eradicate EBV+ TumorsNational Cancer Institute2001
- Pathogenesis Of Oral Hairy LeukoplakiaNational Institute Of Dental &Craniofacial Research1999–2001
- Human Herpesvirus 8 Infection Of Dermal Microvascular Endothelial CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999
- Pathogenesis Of Oral Hairy LeukoplakiaNational Institute Of Dental &Craniofacial Research1997–1998
- Putative Murine Complement Receptor Type 2National Institute Of Allergy And Infectious Diseases1988–1992
- Cloning &Characterization Of The EBV (C3D) ReceptorNational Cancer Institute1988
- Cloning And Characterization Of The EBV (C3D) ReceptorNational Cancer Institute1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
